Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome

• Main Authors: Hanna AF, Abraham B, Hanna A, Smith AJ
• Format: Article
• Language: English
• Published: Dove Medical Press 2017-08-01
• Series: International Medical Case Reports Journal
• Subjects: Lyme Disease; Ketamine; Suicidality; Depression; Post-Treatment Lyme Disease
• Online Access: https://www.dovepress.com/effects-of-intravenous-ketamine-in-a-patient-with-post-treatment-lyme--peer-reviewed-article-IMCRJ

Ashraf F Hanna, Bishoy Abraham, Andrew Hanna, Adam J Smith Department of Pain Management, Florida Spine Institute, Clearwater, FL, USA Abstract: Post-treatment Lyme disease syndrome (PTLDS) is a pain disorder for which there remains no gold standard treatment option. Here, we report a case of PTLDS in a female patient whose pain was refractory to treatment options such as radiofrequency ablation, vitamin infusion therapy, opioid analgesics, and other pharmacotherapies. The patient commenced an experimental intravenous ketamine infusion therapy at the Florida Spine Institute (Clearwater, FL, USA) and achieved relief from her chronic pain, an improved quality of life, reduced depression and suicidal ideation, and reduced opioid consumption. Keywords: chronic Lyme, late Lyme, pain, analgesic, suicidality, depression